FDA NDC Directory · JSON-LD · Markdown

ZITUVIMET XR

NDC 70710-1804 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Generic namesitagliptin and metformin hydrochloride
Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216778
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsMETFORMIN HYDROCHLORIDE (500 mg/1)
SITAGLIPTIN (50 mg/1)
Marketing started20241031
Package count1

External sources

Source: openFDA. Public-domain (CC0).